Found: 31
Select item for more details and to access through your institution.
Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line.
- Published in:
- Journal of Obstetrics & Gynaecology Research, 2012, v. 38, n. 8, p. 1086, doi. 10.1111/j.1447-0756.2011.01841.x
- By:
- Publication type:
- Article
Chronic myelocytic leukemia in pregnancy: A case report describing successful treatment using multimodal therapy.
- Published in:
- Journal of Obstetrics & Gynaecology Research, 2011, v. 37, n. 11, p. 1731, doi. 10.1111/j.1447-0756.2011.01591.x
- By:
- Publication type:
- Article
Overcoming the challenges of drug development in platinumresistant ovarian cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1258228
- By:
- Publication type:
- Article
Bevacizumab in the treatment of ovarian cancer.
- Published in:
- Biologics: Targets & Therapy, 2011, v. 5, p. 1, doi. 10.2147/BTT.S13071
- By:
- Publication type:
- Article
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Carcinoma: Analysis of 30-Day Morbidity and Mortality.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 2, p. 655, doi. 10.1245/s10434-014-4026-6
- By:
- Publication type:
- Article
Neuropilin-2 expression is inhibited by secreted Wnt antagonists and its down-regulation is associated with reduced tumor growth and metastasis in osteosarcoma.
- Published in:
- Molecular Cancer, 2015, v. 14, n. 1, p. 1, doi. 10.1186/s12943-015-0359-4
- By:
- Publication type:
- Article
Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosis.
- Published in:
- Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-55
- By:
- Publication type:
- Article
Comparing loop electrosurgical procedure pathology results in the inpatient and outpatient setting.
- Published in:
- European Journal of Gynaecological Oncology, 2024, v. 45, n. 4, p. 37, doi. 10.22514/ejgo.2024.065
- By:
- Publication type:
- Article
Immunotherapy as a treatment strategy in advanced stage and recurrent endometrial cancer: review of current phase III immunotherapy clinical trials.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211001199
- By:
- Publication type:
- Article
Immunotherapy as a treatment strategy in advanced stage and recurrent endometrial cancer: review of current phase III immunotherapy clinical trials.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211001199
- By:
- Publication type:
- Article
Disseminated Endometriosis and Low-Grade Endometrioid Stromal Sarcoma in a Patient with a History of Uterine Morcellation for Adenomyosis.
- Published in:
- Case Reports in Obstetrics & Gynecology, 2020, p. 1, doi. 10.1155/2020/7201930
- By:
- Publication type:
- Article
Recent Therapeutic Advances in Gynecologic Oncology: A Review.
- Published in:
- Cancers, 2024, v. 16, n. 4, p. 770, doi. 10.3390/cancers16040770
- By:
- Publication type:
- Article
Dkk-3, a Secreted Wnt Antagonist, Suppresses Tumorigenic Potential and PulmonaryMetastasis in Osteosarcoma.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Dkk-3, a Secreted Wnt Antagonist, Suppresses Tumorigenic Potential and Pulmonary Metastasis in Osteosarcoma.
- Published in:
- Sarcoma, 2013, p. 1, doi. 10.1155/2013/147541
- By:
- Publication type:
- Article
Revisiting Immunotherapy in Endometrial Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2024, v. 22, n. 1, p. 28
- By:
- Publication type:
- Article
Immunotherapy Treatment Landscape for Patients With Endometrial Cancer: Current Evidence and Future Opportunities.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 1, p. 27
- By:
- Publication type:
- Article
Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 1, p. 67, doi. 10.1002/1878-0261.12791
- By:
- Publication type:
- Article
Targeting angiogenesis in advanced cervical cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2014, v. 6, n. 6, p. 280, doi. 10.1177/1758834014543794
- By:
- Publication type:
- Article
Intraperitoneal Chemotherapy from Armstrong to HIPEC: Challenges and Promise.
- Published in:
- Current Treatment Options in Oncology, 2014, v. 15, n. 1, p. 27, doi. 10.1007/s11864-013-0264-2
- By:
- Publication type:
- Article
Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes.
- Published in:
- Clinical & Experimental Metastasis, 2020, v. 37, n. 1, p. 107, doi. 10.1007/s10585-019-10007-0
- By:
- Publication type:
- Article
Beyond angiogenesis blockade: targeted therapy for advanced cervical cancer.
- Published in:
- Journal of Gynecologic Oncology, 2014, v. 25, n. 3, p. 249, doi. 10.3802/jgo.2014.25.3.249
- By:
- Publication type:
- Article
Improved Prognosis of Treatment Failure in Cervical Cancer with Non-Tumor Positron Emission Tomography / Computed Tomography Radiomics.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262618
- By:
- Publication type:
- Article
Improved Prognosis of Treatment Failure in Cervical Cancer with Non-Tumor Positron Emission Tomography / Computed Tomography Radiomics.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262618
- By:
- Publication type:
- Article
Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00309-0
- By:
- Publication type:
- Article
Association of Copy Number Variation Signature and Survival in Patients With Serous Ovarian Cancer.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 6, p. e2114162, doi. 10.1001/jamanetworkopen.2021.14162
- By:
- Publication type:
- Article
Mismatch repair in endometrioid endometrial cancer: Increasing our therapeutic proficiency by capitalizing on molecular deficiency.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
KRAS‐Mutated, Estrogen Receptor‐Positive Low‐Grade Serous Ovarian Cancer: Unraveling an Exceptional Response Mystery.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e530, doi. 10.1002/onco.13702
- By:
- Publication type:
- Article
Top advances of the year: Uterine cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 14, p. 2409, doi. 10.1002/cncr.35321
- By:
- Publication type:
- Article
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18613-3
- By:
- Publication type:
- Article
Emerging treatment options for management of malignant ascites in patients with ovarian cancer.
- Published in:
- International Journal of Women's Health, 2012, v. 4, p. 395, doi. 10.2147/IJWH.S29467
- By:
- Publication type:
- Article
Flavokawain B, a kava chalcone, induces apoptosis in synovial sarcoma cell lines.
- Published in:
- Journal of Orthopaedic Research, 2012, v. 30, n. 7, p. 1045, doi. 10.1002/jor.22050
- By:
- Publication type:
- Article